The neuroprotective effect of oxygen after acute stroke in rats has been shown previously. However, the question of optimal dosing still remains unanswered. Thus, we investigated the use of oxygen at different concentrations by either normobaric oxygenation (NBO) or hyperbaric oxygenation (HBO) at different pressures in a model of transient ischemia/reperfusion in rats. Animals underwent 90 min of middle cerebral artery occlusion (MCAO) followed by 90 min of reperfusion before oxygen treatment. Oxygen was applied either by NBO (100% O2; 1.0 absolute atmosphere, ATA) or HBO (100% O2; 1.5, 2.0, 2.5 or 3.0 ATA) for 1 h. Primary endpoints were infarct volume and clinical outcome measured 24 h and 7 days following the MCAO. A statistically significant and long-lasting reduction in infarct volume was seen in the HBO 2.5 ATA and 3.0 ATA groups over a period of 7 days. The reduced infarct volume was accompanied with a statistically significant improvement in clinical outcome in the high-dose oxygen-treated groups. The presented data indicate that oxygen is a highly neuroprotective molecule in transient focal cerebral ischemia in rats, when applied early and at high doses. The effect is dose dependent and shows a superiority of HBO over NBO, when the primary endpoints infarct volume reduction and clinical outcome are analyzed. These data are important for the development of new acute stroke treatment studies in humans.

Keywords:
Oxygen, Hyperbaric oxygenation, Normobaric oxygenation, Ischemia, transient
1.
Lipton P: Ischemic cell death in brain neurons. Physiol Rev 1999;79:1431–1568.
2.
Stingele R, Eschenfelder CC, Zeller J: Therapy of acute stroke. Haemostaseologie 2006;26:316–325.
3.
Yogaratnam JZ, Laden G, Madden LA, Seymour AM, Guvendik L, Cowen M, Greenman J, Cale A, Griffin S: Hyperbaric oxygen: a new drug in myocardial revascularization and protection? Cardiovasc Revasc Med 2006;7:146–154.
4.
Helms AK, Whelan HT, Torbey MT: Hyperbaric oxygen therapy of cerebral ischemia. Cerebrovasc Dis 2005;20:417–426.
5.
Sunami K, Takeda Y, Hashimoto M, Hirakawa M: Hyperbaric oxygen reduces infarct volume in rats by increasing oxygen supply to the ischemic periphery. Crit Care Med 2000;28:2831–2836.
6.
Agardh CD, Zhang H, Smith ML, Siesjo BK: Free radical production and ischemic brain damage: influence of postischemic oxygen tension. Int J Dev Neurosci 1991;9:127–138.
7.
Jain KK: Physical, physiological and biochemical aspects of hyperbaric oxygenation; in Jain KK (ed): Textbook of Hyperbaric Medicine. Göttingen, Hogrefe & Huber, 2004, pp 10–20.
8.
Singhal AB, Dijkhuizen RM, Rosen BR, Lo EH: Normobaric hyperoxia reduces MRI diffusion abnormalities and infarct size in experimental stroke. Neurology 2002;58:945–952.
9.
Singhal AB, Wang X, Sumii T, Mori T, Lo EH: Effects of normobaric hyperoxia in a rat model of focal cerebral ischemia-reperfusion. J Cereb Blood Flow Metab 2002;22:861–868.
10.
Flynn EP, Auer RN: Eubaric hyperoxemia and experimental cerebral infarction. Ann Neurol 2002;52:566–572.
11.
Berrouschot J, Schwab S, Schneider D, Hacke W: Hyperbaric oxygen therapy (HBO) after acute focal cerebral ischemia. Nervenarzt 1998;69:1037–1044.
12.
Zhang JH, Lo T, Mychaskiw G, Colohan A: Mechanisms of hyperbaric oxygen and neuroprotection in stroke. Pathophysiology 2005;12:63–77.
13.
Weinstein PR, Hameroff SR, Johnson PC, Anderson GG: Effect of hyperbaric oxygen therapy or dimethyl sulfoxide on cerebral ischemia in unanesthetized gerbils. Neurosurgery 1986;18:528–532.
14.
Burt JT, Kapp JP, Smith RR: Hyperbaric oxygen and cerebral infarction in the gerbil. Surg Neurol 1987;28:265–268.
15.
Ruiz E, Brunette DD, Robinson EP, Tomlinson MJ, Lange J, Wieland MJ, Sherman R: Cerebral resuscitation after cardiac arrest using hetastarch hemodilution, hyperbaric oxygenation and magnesium ion. Resuscitation 1986;14:213–223.
16.
Takahashi M, Iwatsuki N, Ono K, Tajima T, Akama M, Koga Y: Hyperbaric oxygen therapy accelerates neurologic recovery after 15-minute complete global cerebral ischemia in dogs. Crit Care Med 1992;20:1588–1594.
17.
Iwatsuki N, Takahashi M, Ono K, Tajima T: Hyperbaric oxygen combined with nicardipine administration accelerates neurologic recovery after cerebral ischemia in a canine model. Crit Care Med 1994;22:858–863.
18.
Weinstein PR, Anderson GG, Telles DA: Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats. Neurosurgery 1987;20:518–524.
19.
Mink RB, Dutka AJ: Hyperbaric oxygen after global cerebral ischemia in rabbits reduces brain vascular permeability and blood flow. Stroke 1995;26:2307–2312.
20.
Shiokawa O, Fujishima M, Yanai T, Ibayashi S, Ueda K, Yagi H: Hyperbaric oxygen therapy in experimentally induced acute cerebral ischemia. Undersea Biomed Res 1986;13:337–344.
21.
Kawamura S, Yasui N, Shirasawa M, Fukasawa H: Therapeutic effects of hyperbaric oxygenation on acute focal cerebral ischemia in rats. Surg Neurol 1990;34:101–106.
22.
Lou M, Eschenfelder CC, Herdegen T, Brecht S, Deuschl G: Therapeutic window for use of hyperbaric oxygenation in focal transient ischemia in rats. Stroke 2004;35:578–583.
23.
Veltkamp R, Siebing DA, Heiland S, Schoenffeldt-Varas P, Veltkamp C, Schwaninger M, Schwab S: Hyperbaric oxygen induces rapid protection against focal cerebral ischemia. Brain Res 2005;1037:134–138.
24.
Veltkamp R, Siebing DA, Sun L, Heiland S, Bieber K, Marti HH, Nagel S, Schwab S, Schwaninger M: Hyperbaric oxygen reduces blood-brain barrier damage and edema after transient focal cerebral ischemia. Stroke 2005;36:1679–1683.
25.
Longa EZ, Weinstein PR, Carlson S, Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989;20:84–91.
26.
Schäbitz WR, Sommer C, Zoder W, Kiessling M, Schwaninger M, Schwab S: Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates bax and bcl-2 expression after temporary focal cerebral ischemia. Stroke 2000;31:2212–2217.
27.
Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H: Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986;17:472–476.
28.
Garcia JH, Wagner S, Liu KF, Hu XJ: Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats: statistical validation. Stroke 1995;26:627–634, discussion 635.
29.
Badr AE, Yin W, Mychaskiw G, Zhang JH: Dual effect of HBO on cerebral infarction in MCAO rats. Am J Physiol Regul Integr Comp Physiol 2001;280:R766–R770.
30.
Veltkamp R, Sun L, Herrmann O, Wolferts G, Hagmann S, Siebing DA, Marti HH, Veltkamp C, Schwaninger M: Oxygen therapy in permanent brain ischemia: potential and limitations. Brain Res 2006;1107:185–191.
31.
Kim HY, Singhal AB, Lo EH: Normobaric hyperoxia extends the reperfusion window in focal cerebral ischemia. Ann Neurol 2005;57:571–575.
32.
Richards EM, Fiskum G, Rosenthal RE, Hopkins I, McKenna MC: Hyperoxic reperfusion after global ischemia decreases hippocampal energy metabolism. Stroke 2007;38:1578–1584.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.